Barbara Gayle Duncan is CFO at INTERCEPT PHARMACEUTICALS INC (ICPT). They have made 13 open-market trades across 3 companies since 2013, most recently 2026-06-18.
CIK 0001353128
1 open-market purchase totalling $150K since 2017, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JNCE | SELL | 2020-09-15 | 2020-09-16 | $10.00 | $100K | -13.6% | +6.6% | -27.5% |
| JNCE | SELL | 2018-03-15 | 2018-03-19 | $28.11 | $56K | -17.1% | -27.9% | -70.6% |
| JNCE | SELL | 2018-01-26 | 2018-01-29 | $25.00 | $100K | -6.3% | -17.9% | -19.8% |
| GNMX | BUY | 2017-10-17 | 2017-10-18 | $1.26 | $150K | +21.6% | +9.7% | -6.7% |
| ICPT | SELL | 2016-10-03 | 2016-10-05 | $163.20 | $24K | -9.3% | -35.9% | -32.6% |
| ICPT | SELL | 2016-07-05 | 2016-07-07 | $145.11 | $21K | +1.4% | +12.6% | +7.4% |
| ICPT | SELL | 2016-04-04 | 2016-04-06 | $130.76 | $19K | -8.4% | -18.6% | -12.4% |
| ICPT | SELL | 2016-01-04 | 2016-01-05 | $145.90 | $62K | -18.7% | -31.6% | -10.8% |
| ICPT | SELL | 2016-01-04 | 2016-01-05 | $145.90 | $137K | -18.7% | -31.6% | -10.8% |
| ICPT | SELL · 10b5-1 | 2015-10-01 | 2015-10-05 | $163.17 | $172K | -17.1% | +1.2% | +1.2% |
| ICPT | SELL | 2015-07-02 | 2015-07-07 | $236.26 | $13K | -17.1% | +1.2% | +1.2% |
| ICPT | SELL · 10b5-1 | 2015-07-01 | 2015-07-06 | $242.10 | $242K | -17.1% | +1.2% | +1.2% |
| ICPT | SELL | 2015-04-02 | 2015-04-03 | $277.70 | $11K | -17.1% | +1.2% | +1.2% |
| ICPT | SELL | 2015-03-27 | 2015-04-01 | $289.82 | $290K | -17.1% | +1.2% | +1.2% |
| ICPT | SELL | 2015-01-05 | 2015-01-07 | $176.49 | $25K | -17.1% | +1.2% | +1.2% |
| ICPT | SELL · 10b5-1 | 2015-01-02 | 2015-01-05 | $156.40 | $156K | -17.1% | +1.2% | +1.2% |
| ICPT | SELL · 10b5-1 | 2014-10-01 | 2014-10-03 | $233.12 | $233K | -17.1% | +1.2% | +1.2% |
| ICPT | SELL · 10b5-1 | 2014-04-14 | 2014-04-15 | $279.00 | $322K | -17.1% | +1.2% | +1.2% |
| ICPT | SELL · 10b5-1 | 2014-01-15 | 2014-01-17 | $259.19 | $1.5M | -17.1% | +1.2% | +1.2% |
| ICPT | SELL · 10b5-1 | 2013-07-08 | 2013-07-10 | $45.39 | $1.1M | -17.1% | +1.2% | +1.2% |
| ICPT | SELL · 10b5-1 | 2013-06-19 | 2013-06-21 | $34.50 | $1.7M | -17.1% | +1.2% | +1.2% |
| ICPT | SELL · 10b5-1 | 2013-05-23 | 2013-05-28 | $34.50 | $215K | -17.1% | +1.2% | +1.2% |
| ICPT | SELL · 10b5-1 | 2013-05-20 | 2013-05-22 | $34.50 | $969K | -17.1% | +1.2% | +1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.